BiotechTube
Home/Kamada/Amir London
AL

Amir London

Chief Executive Officer

Kamada

Therapeutic Areas

Rare DiseasesPulmonologyImmunologyTransplant Medicine

Kamada Pipeline

DrugIndicationPhase
Inhaled AAT (KMA-001)Alpha-1 Antitrypsin Deficiency (AATD) with emphysemaPhase 3
IV AATGraft-Versus-Host Disease (GvHD)Phase 2
Anti-Rabies IgG (KamRab)Rabies Post-Exposure ProphylaxisMarketed

Leadership Team at Kamada

GN
Guy Neev
Chief Financial Officer
JB
Joshua Berkman
Senior VP, Corporate Communications & Investor Relations
NG
Nathalie Gordin
Senior VP, Global Human Resources
DE
Dr. Eran Schenker
Chief Medical Officer
ER
Eran Reshef
Senior VP, Global Operations
RK
Roni Klapholz
Senior VP, Global Commercial Operations
View full Kamada profile